Thomás Alexandre Santos, Clinical Oncologist at Medclinica, shared a post by OncoDaily on LinkedIn, adding:
“I am very proud to announce that I am part of the Rio de Janeiro Hub of correspondents for the OncoDaily.
The 17th International Congress of Uro-Oncology, led by Dr. Fernando Maluf, made it clear that Brazil is the epicenter of this transformation. With INCA’s estimate of 781 thousand new cases of cancer per year for the 2026-2028 triennium, precision medicine is no longer the future. I had the opportunity to cover the main highlights of the event, where we discussed how genomics and artificial intelligence are redefining the patient journey.”
Quoting OncoDaily’s post:
“The future of uro-oncology took center stage at URO-ONCO 2026.
From radiogenomics and BRCA-guided therapies to robotic telesurgery and emerging bladder cancer treatments, the congress highlighted how precision oncology continues to reshape cancer care across Latin America.
An insightful congress overview by our Rio de Janeiro Hub member Thomás Alexandre Santos.
